Dynamic Technology Lab Private Ltd bought a new stake in shares of Plexus Corp. (NASDAQ:PLXS – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 11,368 shares of the technology company’s stock, valued at approximately $1,779,000.
Several other large investors have also added to or reduced their stakes in the business. Disciplined Growth Investors Inc. MN boosted its holdings in shares of Plexus by 2.8% during the 3rd quarter. Disciplined Growth Investors Inc. MN now owns 2,168,512 shares of the technology company’s stock worth $296,457,000 after buying an additional 59,465 shares in the last quarter. Pacer Advisors Inc. acquired a new position in shares of Plexus during the 4th quarter valued at $107,489,000. Geode Capital Management LLC boosted its stake in Plexus by 0.8% during the third quarter. Geode Capital Management LLC now owns 653,759 shares of the technology company’s stock worth $89,392,000 after acquiring an additional 4,926 shares in the last quarter. American Century Companies Inc. grew its holdings in Plexus by 72.2% in the fourth quarter. American Century Companies Inc. now owns 544,017 shares of the technology company’s stock worth $85,128,000 after purchasing an additional 228,027 shares during the period. Finally, JPMorgan Chase & Co. increased its stake in Plexus by 146.9% in the fourth quarter. JPMorgan Chase & Co. now owns 258,824 shares of the technology company’s stock valued at $40,501,000 after purchasing an additional 154,003 shares in the last quarter. Institutional investors and hedge funds own 94.45% of the company’s stock.
Plexus Trading Down 3.3 %
PLXS opened at $112.24 on Friday. Plexus Corp. has a fifty-two week low of $92.72 and a fifty-two week high of $172.89. The firm has a market capitalization of $3.03 billion, a PE ratio of 26.04 and a beta of 0.90. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.53 and a quick ratio of 0.70. The company’s 50-day moving average is $132.60 and its 200 day moving average is $145.66.
Insiders Place Their Bets
In other Plexus news, insider Michael J. Running sold 1,250 shares of Plexus stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average price of $138.62, for a total transaction of $173,275.00. Following the transaction, the insider now owns 1,276 shares of the company’s stock, valued at $176,879.12. This trade represents a 49.49 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Frank Zycinski sold 1,200 shares of the business’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $140.84, for a total value of $169,008.00. Following the completion of the transaction, the insider now owns 723 shares in the company, valued at $101,827.32. The trade was a 62.40 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 17,958 shares of company stock valued at $2,551,930 in the last three months. 1.76% of the stock is currently owned by insiders.
Analysts Set New Price Targets
Several brokerages have recently commented on PLXS. Needham & Company LLC raised their target price on Plexus from $162.00 to $172.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Stifel Nicolaus assumed coverage on Plexus in a report on Tuesday, February 4th. They issued a “hold” rating and a $152.00 price target on the stock. Finally, Benchmark restated a “buy” rating and set a $165.00 price objective on shares of Plexus in a report on Wednesday, January 22nd. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $163.00.
View Our Latest Report on PLXS
Plexus Company Profile
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Read More
- Five stocks we like better than Plexus
- What is the S&P 500 and How It is Distinct from Other Indexes
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- 3 Fintech Stocks With Good 2021 Prospects
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS – Free Report).
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.